Evaluating the pharmacotherapy of tirzepatide in patients with type 2 diabetes: The consideration of systemic metabolism

Br J Clin Pharmacol. 2023 Mar;89(3):1222-1223. doi: 10.1111/bcp.15630. Epub 2022 Dec 27.

Yu-Cheng Lee¹, Hsien-Hui Chung^{2

3

4}

¹ Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei City, Taiwan.
² Department of Pharmacy & Clinical Trial Pharmacy, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan.
³ Preventive Medicine Program, Center for General Education, Chung Yuan Christian University, Taoyuan City, Taiwan.
⁴ Department of Pharmacy and Master Program, College of Pharmacy and Health Care, Tajen University, Pingtung County, Taiwan.

No abstract available

Keywords: metabolic hormones; pharmacotherapy; systemic metabolism; tirzepatide; type 2 diabetes.

Publication types